Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial

BACKGROUND: The Global Programme for the Elimination of Lymphatic Filariasis (GPELF) has been in operation since the year 2000, with the aim of eliminating the disease by the year 2020, following five to six rounds of effective annual mass drug administration (MDA). The treatment regimen is ivermect...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, Dziedzom K., Ahorlu, Collins S., Adu-Amankwah, Susan, Otchere, Joseph, Mensah, Sedzro K., Larbi, Irene A., Mensah, George E., Biritwum, Nana-Kwadwo, Boakye, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625710/
https://www.ncbi.nlm.nih.gov/pubmed/28969715
http://dx.doi.org/10.1186/s13063-017-2196-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625710/
https://www.ncbi.nlm.nih.gov/pubmed/28969715
http://dx.doi.org/10.1186/s13063-017-2196-9

Ejemplares similares